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t(1;22)(p13;q13) G- and R- banding. 
Clinics and pathology 
Disease 
Only found so far in M7 ANLL (acute megakaryocytic 
leukaemia); not found in Down syndrome (DS), and 
yet, DS is a disease with highly elevated risk of M7 
(see leukaemia and Down Syndrome); misdiagnoses of 
a solid tumour have been documented. 
Phenotype/cell stem origin 
Megakaryocytic. 
Etiology 
No known toxic exposure. 
Epidemiology 
About 40 known cases; 0% to 3% of paediatric ANLL; 
70 to 100% of infants M7; age: infants: median age 4 
months; 20% are <1 month; 80% are <1 year; 95% are 
<2 years; sex ratio: 15M/24F (non significant). 
Clinics 
No preceeding myelodysplasia, and no history of 
transient leukemoid reaction; prominent organomegaly; 
blood data: moderate WBC; thrombocytopenia; 
myelofibrosis and fibrosis of other organs. 
Cytology 
Platelet-specific markers: platelet-peroxidase by 
electron microscopy, or platelet glycoproteins IIb/IIIa 
(CD41) or IIIa (CD61). 
Treatment 
Bone marrow transplantation is indicated. 
Prognosis 
Complete remission in only 50% of cases; median 




60% of cases (mostly patients under 6 months of age) 
have the t(1;22) as a single anomaly; the remaining 
third of cases (mainly patients above the age of 6 
months) exhibit complex and hyperploid clones, with a 
highly monomorph pattern: +2, +19, +der(1)t(1;22), 
+6, +21 were found in more than 50% of cases each,  
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+10, +7, +15, +18, +8, +20, del(1p), +4, +9, +14, +17, 
add(21p) are also recurrent; survival was equivalent in 
cases with or without a complex karyotype; the 
frequent presence of an additional der(1) indicates that 
the crucial event is likely to lie on the der(1)t(1;22). 
Variants 
One case of complex t(1;22) with a third chromosome 
has been described. 
Genes involved and proteins 
Note 
Genes involved in this leukaemia are still unknown. 
To be noted 
Note 
Individual data on the 39 published cases of t(1;22) and 
a complete bibiography can be found in our t(1;22) 
study group page. 
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